Tweetovi
- Tweetovi, trenutna stranica.
- Tweetovi i odgovori
- Medijski sadržaj
Blokirali ste korisnika/cu @cvirendo
Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @cvirendo
-
Prikvačeni tweet
To celebrate the success of CVIR Endovascular CIRSE now offers an extra 15% discount on the APC to corresponding authors who are CIRSE members in good standing
To apply for the discount contact the editorial team at info@cvirendovascular.orghttps://www.cvirendovascular.org/news/ Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Endovascular treatment of angiomyolipoma is the treatment of choice. A combination of ethanol and lipiodol is one of the ways to do this | https://cvirendovasc.springeropen.com/articles/10.1186/s42155-019-0095-8 …
#irad#openaccess#FOAMradpic.twitter.com/lOj5AmZDhO
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
CVIR Endovascular (Jim Reekers, Editor-in-Chief) proslijedio/la je Tweet
Submit your work to CVIR Endovascular
@cvirendo - CIRSE's open access journal and receive a 15% member discount on the article processing charges! Not a CIRSE member yet? Become a CIRSE junior member and enjoy all#CIRSEsociety membership benefits!@BSIR_News@cirsesocietypic.twitter.com/ogKfq6ZvOn
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Although it is very rare to re-open a common carotid artery, there are some clinical situations where these technologies might be considered. Read more about this: https://bit.ly/2Rxhvto
#irad#FOAMrad#FOAMedpic.twitter.com/QS1VxYKp23
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Great news for German researchers. This deal could be the first important step towards a new scientific publishing landscape in Europe. In this website https://www.springernature.com/gp/open-research/institutional-agreements/oaforgermany … you can find more details about this agreement.
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
CVIR Endovascular (Jim Reekers, Editor-in-Chief) proslijedio/la je Tweet
Not a bad start for 2020 - a huge topic deserving more attention and publications like these are just the beginning. Thanks for your help
@ADiamantop@DeepshaApic.twitter.com/lsD2WCLOF3
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
CVIR Endovascular (Jim Reekers, Editor-in-Chief) proslijedio/la je Tweet
CIRSE system for classification of COMPLICATIONS in
#IRad https://rdcu.be/b0eGI pic.twitter.com/sQZr1hKoNk
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Professor Pereira talking at the Dutch IR day about how to start an IRO practice.pic.twitter.com/64XMjWpxsm
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Dr Jon Bell talking about personalized SIRT. The role of dosimetry.pic.twitter.com/LtpN8Va8sp
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Dr Mehrzad talking at the Dutch Interventional day (RIDN) about percutaneous transhepatic cholangiograhic endobiliary forceps biopsy.pic.twitter.com/Mnz5a0JzSA
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
15% discount on the publication charges in
@cvirendo for all CIRSE members in good standing
Send us an email to get your discount code: info@cvirendovascular.org!
http://www.cvirendovascular.org pic.twitter.com/F8BauLG8fO
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Did you have to pay to go to the toilet?https://twitter.com/GregMakris23/status/1209230467188346881 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
CVIR Endovascular (Jim Reekers, Editor-in-Chief) proslijedio/la je Tweet
Join
@DrBTKatzen and 1,000+ colleagues at#ISET2020, the premier endovascular meeting taking place Jan. 22-25, 2020 in Hollywood, Florida. Register soon to reserve your spot! http://iset.org pic.twitter.com/JQ5bTs4U8hHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Challenges of new Endovascular technologies are numerous: New European regulations, costs, reimbursement, defining efficacy & replacing established older technologies are just some of the hurdles before a new technique becomes part of our daily IR tool box https://cvirendovasc.springeropen.com/articles/10.1186/s42155-019-0086-9 …pic.twitter.com/1cVyTTZVNG
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
CVIR Endovascular (Jim Reekers, Editor-in-Chief) proslijedio/la je Tweet
Women of reproductive age with symptomatic fibroids experience significantly improved quality of life and sexual function, as well as significantly reduced symptoms following treatment with uterine fibroid embolization, a recent
@CVIR_Journal study reportshttp://ow.ly/hj3t30pYZtcHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
CVIR Endovascular (Jim Reekers, Editor-in-Chief) proslijedio/la je Tweet
Major variations in antiplatelet regimes following lower limb angioplasty. https://cvirendovasc.springeropen.com/articles/10.1186/s42155-019-0079-8 …. More great work from
@VascResearchNet@kittywonghfpic.twitter.com/Ncjs5y4ruh
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
CVIR Endovascular (Jim Reekers, Editor-in-Chief) proslijedio/la je Tweet
#ET2020 preliminary programme now online. Secure your spot for the congress today and save up to 53%! https://bit.ly/37FUk6d#embolotherapy#CIRSEsocietypic.twitter.com/Nq71whKEip
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
CVIR Endovascular (Jim Reekers, Editor-in-Chief) proslijedio/la je Tweet
Head over to
@IN_publishing to read their article discussing the launch of the Professor Anna Maria Belli Travelling Grant. https://interventionalnews.com/bsir-anna-mari-belli-grant/ …#BSIR2019@TzeWah1@WIIGS2Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Open access also means open discussion. Have your say & contribute to scientific discussion on endovascular treatments by submitting a Letter to the Editor critiquing a CVIR Endo article. APC waivers available for this article type - contact info@cvirendovascular.org for details!pic.twitter.com/KcTYEirSOK
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
CVIR Endovascular (Jim Reekers, Editor-in-Chief) proslijedio/la je Tweet
Thank You for the Shout out!
@keithppereira#SIR20SEA will be ready for an incredible Annual Meeting. Appreciate everyone volunteering and coming together to help us push#IRAD forward! Do not miss Wednesday Plenary Stay Calm and Call IR!https://twitter.com/keithppereira/status/1198276962608963586 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.